Showing 26–50 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Erick Manuel Delgado Moya, Alain Piétrus, Sergio Oliva
…l takes into account the relationship between Tuberculosis, HIV/AIDS, and diabetes and differentiates resistance cases into MDR-TB (multidrug-resistant tuberculosis) and XDR-TB (extensively drug-resistant tuberculosis). We present the basic results associated with the model and s…
Mhango DV, Mzinza DT, Jambo KC, Mwandumba HC
Purpose of review People living with HIV (PLWH) are commonly coinfected with Mycobacterium tuberculosis, particularly in high-transmission resource-limited regions. Despite expanded access to antiretroviral therapy and tuberculosis (TB) treatment, TB remains the leading cause of …
О. М. Raznatovska, А. В. Федорец, O. O. Furyk, H. I. Makurina, T. O. Hrekova, et al.
…atures of extensively drug-resistant tuberculosis (XDR-TB), HIV and tertiary syphilis co-infection course based on an example from own clinical experience.Materials and methods. A case report of XDR-TB with HIV and tertiary syphilis co-infection course was described based on our …
Ntandazo Dlatu, Lindiwe M Faye, Ncomeka Sineke, Teke Apalata
…cts of body mass index (BMI), human immunodeficiency virus (HIV) status, comorbidities, socioeconomic factors, substance use and DR-TB type. **SETTING:**  The study was conducted in rural Eastern Cape, South Africa. **METHODS:**  This retrospective cohort study was de…
Omid Nikjeh, Seyedehparmis Rejali, Kayvan Sasaninia, Vishwanath Venketaraman
…ored to drug susceptibility, especially in MDR- and XDR-TB. HIV-associated mycobacterial infections-including(TB), disseminatedcomplex (MAC), and Mycobacterium()-remain leading causes of morbidity and mortality in people living with HIV (PLWH). TB continues to account for the hig…
Argita D. Salindri, Maia Kipiani, Nino Lomtadze, Nestani Tukvadze, Zaza Avaliani, et al.
… tuberculosis (TB) (including human immunodeficiency virus [HIV], diabetes, and hepatitis C virus [HCV]) with post-TB mortality. We conducted a retrospective cohort study among persons who initiated treatment for rifampicin-resistant and multi/extensively drug-resistant (RR and M…
Yuanhao Liang, Jiayi Wang, Jianzhou Yang, Jinjia Liu, Xiaofeng He
… and ASMR for all TB forms, including drug-resistant and TB-HIV co-infections. **CONCLUSION:** Sustained investment in TB control programs, particularly in low-SDI regions, is crucial. Addressing drug-resistant TB and TB-HIV co-infection should be prioritized in global public he…
Salindri AD, Kipiani M, Lomtadze N, Tukvadze N, Avaliani Z, et al.
… tuberculosis (TB) (including human immunodeficiency virus [HIV], diabetes, and hepatitis C virus [HCV]) and post-TB mortality. We conducted a retrospective cohort study among persons who initiated treatment for rifampicin-resistant or multi/extensively drug-resistant (RR or M/XD…
Leningrad Oblast Regional Anti-Tuberculosis Dispensary, Slantsy, Slantsevsky District, Leningrad Oblast, Russia, N.A. Barmina, Yu.V. Korneev, Leningrad Oblast Regional Anti-Tuberculosis Dispensary, Slantsy, Slantsevsky District, Leningrad Oblast, Russia
…/extensively drug-resistant (XDR) pathogens and people with HIV and TB co-infection. As a result, cases of TB disease in children with many risk factors for unfavorable outcome of therapy are recorded, leading to subsequent relapse. the aim of the work was to analyze possible cau…
Peng X, Zeng Z, Hassan S, Xue Y
…B), alongside extensively drug-resistant TB (XDR-TB) and TB-HIV co-infection, TB remains one of the lead causes of death arising from infectious disease worldwide, especially in developing countries and disadvantaged populations. Marine natural products (MNPs) have received a lar…
Gourav Rakshit, Venkatesan Jayaprakash
… due to poor ROI, and the existence of co-infections; i.e., HIV, TB, COVID, and HIV-TB-COVID. Following our prior studies described by Stirret et al. in 2008, Ferreras et al. in 2011, and Shyam et al. in 2021, herein we focus on exploring pyrazoline-based mycobactin analogs (non-…
Fang Y, Wang F, Jiang T, Duan J, Huang T, et al.
…ly infected with MPXV, human immunodeficiency virus type 1 (HIV-1), Pneumocystis jiroveci , as well as extensively drug-resistant tuberculosis (XDR-TB). This patient had also received a vaccination for smallpox in the past. Additionally, we provide photographic documentation char…
Larisa Rusakova, С. А. Стерликов, Vladimir Galkin
…e TB (4320) by registration group, age, gender, presence of HIV, proportion of rural population, frequency of bacterial excretion by smear microscopy. <b>Results:</b> In the XDR-TB group, patients prevailed after treatment failure (67.5% compared to 48.9% in the MDR-TB group and …
Nagender Prasad Chenimilla, Pravinya Pittala, Ramulu Madire
…e to the burden of TB. India is grouped under high TB, high HIV associated TB and MDR TB burden countries and 1.24 lakh fell ill with drug resistant TB out of which 56000 were started on second line treatment in 2020. Annually India accounts for 27% of missing TB cases. Diagnosis…
La Manna MP, Orlando V, Tamburini B, Badami GD, Dieli F, et al.
…so effective in patients with human immunodeficiency virus (HIV) coinfection. Therefore, TB control may benefit on novel therapeutic options beyond antimicrobial treatment. Host-directed immunotherapies could offer therapeutic strategies for patients with drug-resistant TB or wit…
Eric R Houpt, MD
…iseases (NIH/NIAID) for US-Russia collaborative research in HIV/tuberculosis (TB). Given the exploratory focus of the protocol and the short time frame of funding (2 years) we will study TB in Irkutsk, in Eastern Siberia. Irkutsk is one of the hardest-hit areas in all of the Russ…
Ato Kwamena Tetteh, Edward Agyarko, Joseph Otchere, Langbong Bimi, Irène Ayi
A 25 year old HIV- seronegative client was diagnosed with pulmonary tuberculosis and placed on Category I (CAT I) treatment. After two months, acid fast bacilli (AFB) persisted in sputum. Rifampicin (Rif) resistance was detected with the GeneXpert MTB-Rif Assay® (Xpert; Cepheid, …
Amish Talwar, Clarisse A. Tsang, Sandy F. Price, Robert Pratt, William L. Walker, et al.
…ion on TB risk factors (e.g., human immunodeficiency virus [HIV] infection status, history of homelessness, and residence in a congregate setting). According to U.S. Census Bureau definitions, a “U.S.-born” person is classified as one born in the United States or a U.S. territory…
Ivana Beatrice Paulus, Feliani Sanjaya, Dewi Sukmawati
…uction: Tuberculosis (TB) and human immunodeficiency virus (HIV) are corelated infectious diseases and their worldwide spread became a global health problem. Moreover, HIV patients with TB are able to develop multi-drug resistance tuberculosis (MDR-TB) and extensive drug-resistan…
Krasnov DV, Skluev SV, Petrova YK, Skvortsov DA, Krasnov VA, et al.
…ely drug-resistant TB, and TB-human immunodeficiency virus (HIV) coinfection require a special approach in anti-TB treatment. Most patients cannot be successfully cured by conventional chemotherapy alone. They need a modern approach using minimally invasive therapeutic and surgic…
James CM Brust, MD, Gary Maartens, MBChB
…is a major global epidemic and poses a particular threat to HIV-infected individuals. With limited effective drugs available for treatment, multidrug-, and extensively drug-resistant TB carry a high mortality rate and threaten global TB and HIV control efforts. New and repurpose…
Shetty NS, Shah I
…d preventive therapy (IPT) in human immunodeficiency virus (HIV)-infected children in India. Materials and methods Factors associated with the development of tuberculosis (TB) in 81 HIV-infected children were analyzed. Results The mean age of presentation was 6.36 ± 3.67 years. A…
Mbuh TP, Mendjime P, Goupeyou-Wandji IA, Donkeng-Donfack VF, Kahou J, et al.
…%) occurred during the first month of therapy and 13(15.5%) HIV-TB co-infected. Male gender [p = 0.006, RR = 2.5 (95% CI: 1.3-4.7)], HIV positive status [p = 0.012, RR = 2.1 (95% CI: 1.2-3.7)], and previous DR-TB status [p = 0.02, RR = 3.9 (95% CI: 1.3-12.0)] were statistically a…
Patrick Howlett, Robert J. Wilkinson, Ben J. Marais
…linical features, Diagnosis, Tuberculosis treatment, TB and HIV, TB in Children, Treatment regimens, Multi-drug resistant and extensively drug resistant TB , Lessons learned in TB treatment and control
Latif A, Ghafoor A, Wali A, Fatima R, Ul-Haq M, et al.
…ent among DR-TB patients with human immunodeficiency virus (HIV) co-infection (OR 11.58, 95%CI 2.20-60.72), extensively drug-resistant TB patients (OR 5.36, 95%CI 1.00-28.72), patients with exposure to both first-line and second-line anti-tuberculosis drugs (OR 2.45, 95%CI 1.21-4…